Robert Pickett Dickson, MD
Galen B Toews M.D. Legacy Professor of Pulmonary and Critical Care Medicine
Associate Professor of Internal Medicine
Associate Professor of Microbiology and Immunology
Associate Fellowship Director, Pulmonary and Critical Care Medicine
[email protected]

Available to mentor

Robert Pickett Dickson, MD
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Robert Dickson is the Galen B. Toews Legacy Professor of Pulmonary and Critical Care Medicine at the University of Medicine, and an Associate Professor in the Division of Pulmonary and Critical Care Medicine and the Department of Microbiology and Immunology at the University of Michigan. Clinically, he cares for patient in the Critical Care Medicine Unit and serves as the program physician for the Washtenaw County Tuberculosis Clinic.

    Dr. Dickson serves as Associate Chief (Research) for the Division of Pulmonary & Critical Care Medicine and as Deputy Director of the Weil Institute for Critical Care Research & Innovation. He is the Program Director of the University of Michigan’s Multidisciplinary Training Program in Lung Disease (T32HL007749), and Associate Program Director (Research) for the Pulmonary and Critical Care Medicine Fellowship Program.

    Qualifications
    • MD
      Duke University, Durham, 2007
    • BA
      St. John's College, Annapolis, 2000
    Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Global REACH
    Research Overview

    In the lab, Dr. Dickson complements his clinical and research background in the pathophysiology of lung disease and critical illness with the culture-independent techniques of microbial ecology. Diseases of interest include the acute respiratory distress syndrome (ARDS), sepsis, pneumonia, pulmonary fibrosis, and lung transplant rejection. His laboratory specializes in integrative translational research, spanning from molecular characterization of respiratory microbiota to animal modeling of sepsis and lung injury to prospective trials of human subjects.

    Dr. Dickson's expertise in the study of the microbiome's role in critical illness and lung disease is reflected by first- and senior-author publications in Science Translational Medicine, Nature Microbiology, The Lancet, the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He has authored more than 125 publications which have been cited more than 12,000 times. His research is supported by the National Institutes for Health, the European Commission, and institutional support.

    He is a Specialist Editor of the European Respiratory Journal, and a member of the Editorial Boards of the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He is an elected member of the American Society for Clinical Investigation, and a Fellow of the European Respiratory Society.

    Recent Publications See All Publications
    • Preprint
      A rapid, inexpensive, culture-free, universal bacterial identification system using internal transcribed spacer targeting primers: a proof-of-principle study
      Asthana V, Nieves EM, Bugga P, Smith C, Dunn T, Narayanasamy S, Dickson RP, VanEpps JS. 2024 Sep 19; Cold Spring Harbor Laboratory, DOI:10.1101/2024.09.15.613074
    • Journal Article
      Reevaluating Piperacillin-Tazobactam Mortality-Reply.
      Chanderraj R, Dickson RP, Sjoding MW. JAMA Intern Med, 2024 Aug 26; DOI:10.1001/jamainternmed.2024.4120
      PMID: 39186296
    • Preprint
      Respiratory virome convergence precedes Hospital-Acquired Pneumonia in critically ill patients
      Josset L, Anani H, Destras G, Bulteau S, Castain L, Semanas Q, Burfin G, Martin F, Poulain C, Dickson R, Bressollette-Bodin C, Roquilly A. 2024 Aug 5; Springer Science and Business Media LLC, DOI:10.21203/rs.3.rs-4808570/v1
    • Journal Article
      INFLAMMATORY RESPONSES TO POLYMICROBIAL INTRA-ABDOMINAL SEPSIS ARE HIGHLY VARIABLE BUT STRONGLY CORRELATED TO ENTEROBACTERIACEAE OUTGROWTH.
      Bongers KS, Chanderraj R, Deng H, Song Y, Newstead MW, Metcalf JD, Falkowski NR, Puranik N, Kurabayashi K, Dickson RP, Singer BH. Shock, 2024 Aug 1; 62 (2): 275 - 285. DOI:10.1097/SHK.0000000000002402
      PMID: 38888452
    • Journal Article
      Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime.
      Chanderraj R, Admon AJ, He Y, Nuppnau M, Albin OR, Prescott HC, Dickson RP, Sjoding MW. JAMA Intern Med, 2024 Jul 1; 184 (7): 769 - 777. DOI:10.1001/jamainternmed.2024.0581
      PMID: 38739397
    • Journal Article
      The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
      Combs MP, Luth JE, Falkowski NR, Wheeler DS, Walker NM, Erb-Downward JR, Wakeam E, Sjoding MW, Dunlap DG, Admon AJ, Dickson RP, Lama VN. Am J Respir Crit Care Med, 2024 Jun 1; 209 (11): 1360 - 1375. DOI:10.1164/rccm.202308-1326OC
      PMID: 38271553
    • Journal Article
      Urgent Need for Regulatory Oversight of Human Cells, Tissues, and Cellular and Tissue-Based Products.
      Dickson RP, Dingell DA. JAMA, 2024 May 28; 331 (20): 1703 - 1704. DOI:10.1001/jama.2024.6834
      PMID: 38696201
    • Presentation
      “Bridging the gap: translational studies in ARDS, pneumonia, and sepsis”
      Dickson R. 2024 May 22;